Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Aeterna Zentaris Inc (AEZS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Aeterna Zentaris's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.1887 -0.0032    -1.67%
24/06 - Closed. Currency in USD ( Disclaimer )
After Hours
0.1866
-0.0021
-1.1129%
19:25:16 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  CA0079754028 
CUSIP:  007975402
  • Volume: 252,006
  • Bid/Ask: 0.1871 / 0.1905
  • Day's Range: 0.1853 - 0.1956
Aeterna Zentaris 0.1887 -0.0032 -1.67%
IndustryBiotechnology
SectorHealthcare
Employees

12

Equity Type

ORD

Aeterna Zentaris Inc. is a specialty biopharmaceutical company, which is engaged in commercializing and developing therapeutics and diagnostic tests. The Company's lead product, Macrilen (macimorelin), is an oral test indicated for the diagnosis of patients with adult growth hormone deficiency (AGHD). Macrilen (macimorelin) is an orally available peptidomimetic ghrelin receptor agonist that stimulates the secretion of growth hormone by binding to the ghrelin receptor (GHSR-1a) and has uses in both endocrinology and oncology indications. The Company is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). It is also developing oral prophylactic bacterial vaccines against each of SARS-CoV-2, the virus that causes COVID-19, and Chlamydia Trachomatis. The Company focuses on the commercialization of macimorelin in Asia and the rest of the world.

Contact Information

Top Executives

Name Age Since Title
Gilles R. Gagnon 67 2007 Independent Director
Dennis Turpin - 1999 Independent Director
Jacques Gauthier 59 2004 Director of Atrium Biotechnologies Inc
Ulf R. Rapp - - Member of the Scientific Advisory Board
Klaus Paulini - 2019 President, CEO & Executive Director
Daniel Douglas Von Hoff 73 2005 Member of the Scientific Advisory Board
René Frydman - - Member of the Scientific Advisory Board
Alan H. DeCherney - - Member of the Scientific Advisory Board
Frans M. J. Debruyne - - Member of the Scientific Advisory Board
Klaus H. R. Diedrich - - Member of the Scientific Advisory Board
Peter G. Edwards 60 2020 Independent Director
Marcel Verheij - - Member of the Scientific Advisory Board
Gerald Batist - - Member of the Scientific Advisory Board
Hartmut Michel - - Member of the Scientific Advisory Board
Carolyn S. Egbert - 2012 Independent Chair of the Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AEZS Comments

Write your thoughts about AEterna Zentaris Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Joel Sebastian
Joel Sebastian Apr 25, 2022 12:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I don't know what is really going on with stock
Ole Rii
Ole Rii Mar 24, 2022 11:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2 USD by the end of the year
John Gomez
John Gomez Mar 24, 2022 11:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hope!
John Gomez
John Gomez Mar 24, 2022 11:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I hope!
TheJavi GP
TheJavi GP Nov 26, 2021 5:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sale una nueva variante y no veas la k se lía
John Napier
John Napier Oct 01, 2021 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why is this 🚀?
Bruce Hendrickson
Bruce Hendrickson Oct 01, 2021 9:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There is hype on new COVID treatment announcement and it is/was oversold
Bruce Hendrickson
Bruce Hendrickson Sep 30, 2021 9:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Seeing a lot of predictions for 3.50 in the next few days
Brian Solis
Brian Solis Sep 30, 2021 9:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why?
Brian Solis
Brian Solis Jul 08, 2021 5:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
let's get that oral vaccine out
Walaa Ahmed
Walaa Ahmed Jun 21, 2021 3:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Than ?
Michael Farrell
Michael Farrell Jun 08, 2021 10:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's spelled -ess h eye tee-
Michael Farrell
Michael Farrell Jun 08, 2021 10:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I used to be an enthusiastic bag holder too,...,woke up,dumped the ****
Glenn AM
Glenn AM May 27, 2021 3:14PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.handelsblatt.com/dpa/wirtschaft-handel-und-finanzen-verband-corona-impfstoffe-zweiter-generation-vielleicht-schon-2021/27222440.html?ticket=ST-5153637-HIXgEEndEVksGk2n6CrC-ap2
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email